Spinal Cord Stimulation Market Size, Share, Growth Analysis, By Indication (Failed Back Surgery Syndrome, Complex Regional Pain Syndrome), By Product (Rechargeable Devices, Non-Rechargeable Devices), By End User (Hospitals), By Region - Industry Forecast 2024-2031

Due to the company's strong emphasis on research and development (R&D) as well as significant acquisitions that will help it in creating cutting-edge devices to manage chronic pain, Medtronic dominated the market by having accounting for a huge revenue share. Healthcare professionals prefer Medtronic spinal cord stimulators because they are easy to use, have long battery lives, produce superior clinical results, and come with outstanding customer support.

Spinal Cord Stimulation Market Top Players Company Profiles

• Medtronic plc (Ireland) 
• Boston Scientific Corporation (USA) 
• Abbott Laboratories (USA) 
• Nevro Corp. (USA) 
• Stimwave Technologies, Inc. (USA) 
• Saluda Medical Pty Ltd. (Australia) 
• Synapse Biomedical Inc. (USA) 
• Cirtec Medical (USA) 
• Nalu Medical, Inc. (USA) 
• Beijing PINS Medical Co., Ltd. (China) 
• Gimer Medical (China) 
• BIOTRONIK SE & Co. KG (Germany) 
• St. Jude Medical, Inc. (acquired by Abbott) (USA) 
• NeuroSigma, Inc. (USA) 
• Greatbatch, Inc. (USA) 
• Curonix LLC (USA) 
• Teliatry, Inc. (USA) 
• Spinal Modulation (USA) 
• NevroSpin (USA) 
• Axonics Modulation Technologies, Inc. (USA)

Spinal Cord Stimulation Market Recent Development

• In March 2022, Saluda's spinal cord stimulation system was approved by the FDA for chronic pain. 
• The Evoke system stimulates the spinal cord to alleviate the effects of chronic pain in the trunk and limbs, such as failed back surgery syndrome, intractable low back pain, and leg pain, and it constantly adjusts its therapy to optimize treatment.